Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

BioDiem begins four studies of BDM-E at Monash University

Aug. 31, 2007

Enrollment for Medidur human PK study commences

Aug. 27, 2007

U.S. launch of AzaSite reported by InSite Vision and Inspire

Aug. 14, 2007

New experimental gene therapy approach for the treatment of retinitis pigmentosa

Aug. 14, 2007

Novel gene therapy approach for the treatment of juvenile retinoschisis reported

Aug. 14, 2007

Targeting amyloid-beta, a novel approach in glaucoma therapy

Aug. 13, 2007

Lux Biosciences' LX-211 granted fast track designation for the treatment of uveitis

Aug. 8, 2007

Regeneron and Bayer begin phase III study of VEGF Trap-Eye for wet AMD

Aug. 8, 2007

Orphan drug designation of LX-211 recommended by EMEA committee

Aug. 7, 2007

TargeGen begins phase II trial of TG-100801 eye drops for AMD

Aug. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...